Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proliferative Breast Disease”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Very early researchStudy completedNCT03954015
What this trial is testing

Comparison of Three Methods for Early Detection of Breast Cancer

Who this might be right for
Proliferative Breast Disease
Mayo Clinic 3
Not applicableUnknownNCT02600442
What this trial is testing

Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers

Who this might be right for
Breast NeoplasmsBreast Cancer
Assistance Publique - Hôpitaux de Paris 168
Testing effectiveness (Phase 2)WithdrawnNCT01814865
What this trial is testing

Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

Who this might be right for
Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer
British Columbia Cancer Agency
Early research (Phase 1)Study completedNCT02922127
What this trial is testing

Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation

Who this might be right for
Contraception
Columbia University 29
Testing effectiveness (Phase 2)Study completedNCT01965522
What this trial is testing

Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer

Who this might be right for
Early Stage Breast Cancer
Juravinski Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT01500577
What this trial is testing

A Prevention Trial in Subjects at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
European Institute of Oncology 150
Testing effectiveness (Phase 2)Study completedNCT00816244
What this trial is testing

Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer

Who this might be right for
Breast CancerPostmenopausal
Lund University Hospital 50
Not applicableEnded earlyNCT01712815
What this trial is testing

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer

Who this might be right for
HER2-positive Breast CancerRecurrent Breast CancerStage IA Breast Cancer+6 more
University of Southern California 12
Testing effectiveness (Phase 2)Study completedNCT00093002
What this trial is testing

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 179
Testing effectiveness (Phase 2)Study completedNCT01367288
What this trial is testing

Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers

Who this might be right for
Locally Advanced Breast CancerDuctal Histologic TypeWithout Her 2 Overexpression
Hospices Civils de Lyon 53
Early research (Phase 1)Study completedNCT00968656
What this trial is testing

Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1

Who this might be right for
Breast CancerHead and Neck CancerDiffuse Large B-cell Lymphoma
Washington University School of Medicine 31
Not applicableUnknownNCT00926315
What this trial is testing

Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation

Who this might be right for
Breast NeoplasmsPostmenopausal Disorder
University of Sao Paulo General Hospital 60
Not applicableStudy completedNCT01273415
What this trial is testing

Usefulness of Ki67 Index in Hormone Receptor-positive Breast Cancer

Who this might be right for
Breast Cancer
Samsung Medical Center 1,070
Early research (Phase 1)Looking for participantsNCT06307249
What this trial is testing

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Who this might be right for
CancerSolid TumorColorectal Cancer+7 more
Lebanese University 50
Testing effectiveness (Phase 2)Looking for participantsNCT05728268
What this trial is testing

Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index

Who this might be right for
Breast Cancer
Shantou Central Hospital 64
Large-scale testing (Phase 3)Study completedNCT00725374
What this trial is testing

Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469)

Who this might be right for
Breast Cancer
Organon and Co 102
Testing effectiveness (Phase 2)Study completedNCT01015131
What this trial is testing

18F-FLT-PET in Breast Cancer (MK-0000-139)

Who this might be right for
Breast Cancer
Merck Sharp & Dohme LLC 46
Not applicableStudy completedNCT00259597
What this trial is testing

Nuclear Morphology of Breast Cells in Ductal Lavage

Who this might be right for
Benign Breast Disease
University of Michigan 57
Testing effectiveness (Phase 2)UnknownNCT03688958
What this trial is testing

Iodine Supplementation on Breast Cancer

Who this might be right for
Breast Cancer
Universidad Nacional Autonoma de Mexico 120
Early research (Phase 1)Ended earlyNCT02936206
What this trial is testing

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Who this might be right for
Breast Cancer
Icahn School of Medicine at Mount Sinai 2
Next Page